Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-10
2009-06-30
Chang, Celia (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S561000, C549S513000, C564S338000
Reexamination Certificate
active
07553971
ABSTRACT:
The invention provides novel β2adrenergic receptor agonist compounds of formula (I):wherein R1-R13and w have any of the values described in the specification. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
REFERENCES:
patent: 4894219 (1990-01-01), Baker et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 5064863 (1991-11-01), Alig et al.
patent: 5434304 (1995-07-01), Trofast et al.
patent: 5750701 (1998-05-01), Beeley et al.
patent: 6265581 (2001-07-01), Bell et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 6346532 (2002-02-01), Maruyama et al.
patent: 6576793 (2003-06-01), Moran et al.
patent: 6653323 (2003-11-01), Moran et al.
patent: 2005/0075394 (2005-04-01), Box et al.
patent: 2005/0113411 (2005-05-01), Linsell et al.
patent: 2005/0159448 (2005-07-01), McKinnell et al.
patent: 2005/0192316 (2005-09-01), Moran et al.
patent: 2005/0272769 (2005-12-01), Linsell
patent: 2006/0019991 (2006-01-01), McKinnell et al.
patent: 2006/0058530 (2006-03-01), Linsell et al.
patent: BE 849 794 (1977-04-01), None
patent: WO 00/40560 (2000-07-01), None
patent: WO 00/75114 (2000-12-01), None
patent: WO 01/42193 (2001-06-01), None
patent: WO 02/00622 (2002-01-01), None
patent: WO 02/066422 (2002-08-01), None
patent: WO 02/070490 (2002-09-01), None
Exhibit I.
Exhibit II.
Molander et al. “Scope of the Suzuki-Miyaura . . . ” J. Org. Chem. v.74 p. 973-980 (2009).
Morie et al. “Preparation of . . . ” CA 138:39100 (2002).
Aggen James
Church Timothy J.
Jacobsen John R.
Leadbetter Michael R.
Moran Edmund J.
Chang Celia
Hagenah Jeffrey A.
Saxon Roberta P.
Theravance Inc.
LandOfFree
Aryl aniline β2 adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl aniline β2 adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl aniline β2 adrenergic receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4128877